This raises questions about whether GLP-1 RAs may contribute to muscle loss in vulnerable populations, such as older adults or those with pre-existing frailty
Edwards George JB, Aideyan B, Yates K, Voorhees KN, OFlynn J, Sweet K et al
"A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Are Overweight (TRIUMPH-1)." NCT05929066
View the current JRNYS program details (official JRNYS page) JRNYS GLP-1 Medication Options: Semaglutide, Tirzepatide, Liraglutide, Ozempic, Mounjaro, Wegovy, and Zepbound JRNYS-affiliated providers may discuss and prescribe medications across several GLP-1 and related categories
Many women report unexpected pregnancies while taking these drugs
The NHS does not prescribe GLP-1 medications for Hashimoto's unless you also meet strict criteria for type 2 diabetes or obesity with complications as outlined in NICE guidance